Obinutuzumab Beta Combined With Low-dose Glucocorticoid in New-onset ANCA-Associated Glomerulonephritis

Clinical trial NCT07746180 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07746180
Sponsor: Chinese PLA General Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

ANCA-Associated Glomerulonephritis (AAGN)ANCA-Associated Vasculitis (AAV)

Start date: 2026-07-31
Primary completion: 2028-10-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.